Brickell Biotech Stock Price on July 29, 2022

BBI Stock  USD 0.91  0.01  1.11%   
Below is the normalized historical share price chart for Brickell Biotech extending back to March 10, 1993. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Brickell Biotech stands at 0.91, as last reported on the 18th of April 2024, with the highest price reaching 0.91 and the lowest price hitting 0.90 during the day.
IPO Date
15th of March 1993
200 Day MA
8.1257
50 Day MA
2.9954
Beta
0.0796
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in Brickell Stock, it is important to understand the factors that can impact its price. Brickell Biotech secures Sharpe Ratio (or Efficiency) of -0.0523, which signifies that the company had a -0.0523% return per unit of risk over the last 3 months. Brickell Biotech exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Brickell Biotech's Mean Deviation of 1.22, standard deviation of 1.89, and Risk Adjusted Performance of (0.02) to double-check the risk estimate we provide.
  
As of now, Brickell Biotech's Capital Stock is increasing as compared to previous years. The Brickell Biotech's current Stock Based Compensation To Revenue is estimated to increase to 6.76, while Total Stockholder Equity is projected to decrease to under 27.2 M. . As of now, Brickell Biotech's Price To Book Ratio is increasing as compared to previous years. The Brickell Biotech's current Price Sales Ratio is estimated to increase to 0.96, while Price Earnings Ratio is projected to decrease to (0.01). Brickell Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0523

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBBI

Estimated Market Risk

 1.9
  actual daily
16
84% of assets are more volatile

Expected Return

 -0.1
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.05
  actual daily
0
Most of other assets perform better
Based on monthly moving average Brickell Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Brickell Biotech by adding Brickell Biotech to a well-diversified portfolio.
Price Book
0.4099
Enterprise Value Ebitda
0.2799
Price Sales
1.4546
Shares Float
2.7 M
Wall Street Target Price
17.83

Brickell Biotech Valuation on July 29, 2022

It is possible to determine the worth of Brickell Biotech on a given historical date. On July 29, 2022 Brickell was worth 2.95 at the beginning of the trading date compared to the closed value of 2.97. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Brickell Biotech stock. Still, in general, we apply an absolute valuation method to find Brickell Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Brickell Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Brickell Biotech's related companies.
 Open High Low Close Volume
  3.04    3.10    2.99    3.01    45,300  
07/29/2022
  2.95    3.02    2.88    2.97    66,800  
  2.91    3.13    2.88    3.05    98,100  
Backtest Brickell Biotech  |  Brickell Biotech History  |  Brickell Biotech Valuation   PreviousNext  
Open Value
2.95
2.97
Closing Value
8.65
Upside

Brickell Biotech Trading Date Momentum on July 29, 2022

On August 01 2022 Brickell Biotech was traded for  3.05  at the closing time. Highest Brickell Biotech's price during the trading hours was 3.13  and the lowest price during the day was  2.88 . The net volume was 98.1 K. The overall trading history on the 1st of August contributed to the next trading period price growth. The overall trading delta to the next next day price was 2.69% . The overall trading delta to current price is 34.01% .

Brickell Biotech Fundamentals Correlations and Trends

By evaluating Brickell Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Brickell Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Brickell financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Brickell Biotech Stock history

Brickell Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Brickell is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Brickell Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Brickell Biotech stock prices may prove useful in developing a viable investing in Brickell Biotech
Last ReportedProjected for Next Year
Common Stock Shares Outstanding2.1 M2.2 M
Net Loss-35.5 M-33.8 M

Brickell Biotech Quarterly Net Working Capital

15.38 Million

Brickell Biotech Stock Technical Analysis

Brickell Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Brickell Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Brickell Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Brickell Biotech Period Price Range

Low
July 29, 2022
0.02  0.68%
High

 2.95 

     

 2.97 

Brickell Biotech April 18, 2024 Market Strength

Market strength indicators help investors to evaluate how Brickell Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Brickell Biotech shares will generate the highest return on investment. By undertsting and applying Brickell Biotech stock market strength indicators, traders can identify Brickell Biotech entry and exit signals to maximize returns

Brickell Biotech Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Brickell Biotech's price direction in advance. Along with the technical and fundamental analysis of Brickell Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Brickell to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Brickell Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brickell Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brickell Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brickell Biotech Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brickell Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
For more detail on how to invest in Brickell Stock please use our How to Invest in Brickell Biotech guide.
Note that the Brickell Biotech information on this page should be used as a complementary analysis to other Brickell Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Complementary Tools for Brickell Stock analysis

When running Brickell Biotech's price analysis, check to measure Brickell Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brickell Biotech is operating at the current time. Most of Brickell Biotech's value examination focuses on studying past and present price action to predict the probability of Brickell Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brickell Biotech's price. Additionally, you may evaluate how the addition of Brickell Biotech to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Fundamental Analysis
View fundamental data based on most recent published financial statements
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stocks Directory
Find actively traded stocks across global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Is Brickell Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Brickell Biotech. If investors know Brickell will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Brickell Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.42)
Revenue Per Share
1.94
Quarterly Revenue Growth
27.576
Return On Assets
(0.80)
Return On Equity
(1.57)
The market value of Brickell Biotech is measured differently than its book value, which is the value of Brickell that is recorded on the company's balance sheet. Investors also form their own opinion of Brickell Biotech's value that differs from its market value or its book value, called intrinsic value, which is Brickell Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Brickell Biotech's market value can be influenced by many factors that don't directly affect Brickell Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Brickell Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brickell Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brickell Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.